Values First Advisors, Inc. - ASCENDIS PHARMA A/S ownership

Back to all holdings Add to watchlist

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
Values First Advisors, Inc. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$958,412
+8.2%
10,235
+3.2%
0.62%
+15.9%
Q2 2023$885,412
+11.5%
9,921
+34.0%
0.53%
+5.5%
Q1 2023$793,903
-10.4%
7,404
+2.1%
0.51%
-18.1%
Q4 2022$885,926
-7.0%
7,254
-21.4%
0.62%
-9.8%
Q3 2022$953,000
-18.2%
9,227
-26.4%
0.68%
-17.3%
Q2 2022$1,165,000
-29.4%
12,529
-10.9%
0.83%
-20.5%
Q1 2022$1,651,000
+22.6%
14,065
+40.5%
1.04%
+30.6%
Q4 2021$1,347,000
-39.0%
10,009
-27.8%
0.80%
-44.3%
Q3 2021$2,210,000
+52.8%
13,868
+26.2%
1.43%
+46.0%
Q2 2021$1,446,000
+8.6%
10,991
+6.3%
0.98%
-0.2%
Q1 2021$1,332,000
-4.0%
10,339
+24.3%
0.98%
-11.0%
Q4 2020$1,387,000
+18.9%
8,316
+10.0%
1.10%
+3.0%
Q3 2020$1,167,000
+1.3%
7,561
-2.9%
1.07%
-6.0%
Q2 2020$1,152,000
+22.8%
7,789
-6.5%
1.14%
+1.3%
Q1 2020$937,803
-34.7%
8,328
-19.3%
1.13%
-18.8%
Q4 2019$1,436,000–10,323–1.39%–
 Download
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders